Skip to main content

CRYO CELL INTERNATIONAL INC

For the period ended Nov 30, 2023. Filed Feb 28, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 28, 2024

CCEL$4.87-0.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Power of Attorney (included on signature page)

POWER OFATTORNEY

Each of the undersigned officers and directors of Cryo-Cell International, Inc., hereby constitutes and appoints David Portnoy, Mark Portnoy and Jill Taymans, each their true and lawful attorneys-in-fact and agents, for them and in their name, place and stead, in any and all capacities, to sign their names to any and all amendments to this Report on Form 10-K, and other related documents, and to cause the same to be filed with the Securities and Exchange Commission, granting unto said attorneys, full power and authority to do and perform any act and thing necessary and proper to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present, and the undersigned for himself or herself hereby ratifies and confirms all that said attorney shall lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SIGNATURETITLEDATE
/s/ David PortnoyChairman of the Board and
David PortnoyCo-Chief Executive Officer
(principal executive officer)February 28, 2024
/s/ Mark PortnoyCo-Chief Executive OfficerFebruary 28, 2024
Mark Portnoy
/s/ Jill TaymansChief Financial Officer
Jill Taymans(principal financial and accounting officer)February 28, 2024
/s/ Harold BergerDirectorFebruary 28, 2024
Harold Berger
/s/ Daniel MizrahiDirectorFebruary 28, 2024
Daniel Mizrahi
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.